Mandate

Vinge advises J.P. Morgan, Nordea and SEB Enskilda in connection with SAS rights issue

February 09, 2010

Vinge is advising J.P Morgan, Nordea and SEB Enskilda in connection with SAS AB’s new issue of ordinary shares for approximately SEK 5 billion with pre-emption rights for the company’s existing shareholders. J.P. Morgan, Nordea and SEB Enskilda which are acting as Joint Global Co-ordinators, Joint Lead Managers and Joint Bookrunners in the rights issue have, together with DnB NOR Markets, the Royal Bank of Scotland and Danske Markets, confirmed their willingness, subject to certain conditions, to severally enter into underwriting agreements in respect of 42.4 per cent of the shares in the issue.

SAS AB is listed on NASDAQ OMX Stockholm, NASDAQ OMX Copenhagen and Oslo Børs.

Vinge’s team primarily consisted of partners Göran Nyström, Rikard Stenberg and Lennart Larsson together with associates Johan Thiman, Johan Norström and Mårten Svensson.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025